Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigation.

MLA

Yuile, Alexander, et al. “Increased Rates of Cetuximab Reactions in Tick Prevalent Regions and a Proposed Protocol for Risk Mitigation.” Asia Pacific Journal of Clinical Oncology, vol. 17, no. 6, Dec. 2021, pp. 448–53. EBSCOhost, https://doi.org/10.1111/ajco.13465.

APA

Yuile, A., Fanuli, C., van Nunen, S., Diakos, C., Clarke, S., Steiner, C., MacMillan, R., Oatley, M., & Pavlakis, N. (2021). Increased rates of cetuximab reactions in tick prevalent regions and a proposed protocol for risk mitigation. Asia Pacific Journal of Clinical Oncology, 17(6), 448–453. https://doi.org/10.1111/ajco.13465

Chicago

Yuile, Alexander, Claudia Fanuli, Sheryl van Nunen, Connie Diakos, Stephen Clarke, Christian Steiner, Robyn MacMillan, Meredith Oatley, and Nick Pavlakis. 2021. “Increased Rates of Cetuximab Reactions in Tick Prevalent Regions and a Proposed Protocol for Risk Mitigation.” Asia Pacific Journal of Clinical Oncology 17 (6): 448–53. doi:10.1111/ajco.13465.